The myMerlin™ mobile app accompanies Abbott’s Bluetooth®-enabled wearable cardiac monitors. The app is compatible with your patient’s iPhone‡ or Android‡ smartphone.* When paired with an attached Abbott ICM, the myMerlin mobile app provides data 20 times faster than other ICMs, making it easy, effective and confidential to monitor your patient’s heart.
The myMerlin™ mobile app accompanies Abbott’s Bluetooth®-enabled wearable cardiac monitors. The app is compatible with your patient’s iPhone‡ or Android‡ smartphone.* When paired with an attached Abbott ICM, the myMerlin mobile app provides data 20 times faster than other ICMs, making it easy, effective and confidential to monitor your patient’s heart.
The HeartMate II™ LVAD is designed to provide short-term or long-term circulatory support for patients with advanced heart failure and is indicated in the United States for both target therapy and bridge to transplantation. Backed by over 10 years of data, the HeartMate II LVAD is the most widely used and most extensively studied LVAD in the world, implanted in more than 27,000 patients worldwide.
Transmitters with MerlinOnDemand™ can instantly interrogate your patient’s implanted cardiac device in a hospital setting and provide printed reports without the physical presence of an Abbott representative. The MerlinOnDemand feature represents a solution for maintaining your department’s efficiency and a high level of patient care.
Quartet™ four-pole LV lead offers superior deliverability with exceptional stability and performance. With four electrodes and up to 14 pacing configurations, the quadripolar system provides left ventricular (LV) pacing at the site of choice without sacrificing lead stability.
Follow us:
© 2022 AventinHealty.com. All rights reserved.
